Other OTC - Delayed Quote USD

Health-Chem Corporation (HCLC)

0.0001 0.0000 (0.00%)
As of November 28 at 3:00 PM EST. Market Open.
Loading Chart for HCLC
DELL
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0001
  • Volume 260
  • Avg. Volume 0
  • Market Cap (intraday) 73,985
  • Beta (5Y Monthly) 43.47
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.

55

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: HCLC

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HCLC
0.00%
S&P 500
7.05%

1-Year Return

HCLC
0.00%
S&P 500
25.41%

3-Year Return

HCLC
99.42%
S&P 500
22.15%

5-Year Return

HCLC
97.96%
S&P 500
74.50%

Compare To: HCLC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HCLC

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.01

  • Enterprise Value/EBITDA

    0.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.87%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.28M

  • Net Income Avi to Common (ttm)

    -837k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.85M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights: HCLC